Sclareol Inhibit Cell Growth and Induces Apoptosis via Activation of p53/p21 Signaling Pathways in Human Oral Squamous Cell Carcinoma Cells
Journal of Biochemical and Molecular Toxicology · 2026-09 · 40 (9)
DOI: 10.1002/jbt.71106 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, online erschienen am 07.09.2026. Verfasst von Anandhi Nallu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Biotechnology, Faculty of Science, Annamalai University, Annamalainagar, Tamil Nadu, India. Hauptthemen laut MEDLINE: Apoptosis, Tumor Suppressor Protein p53, Mouth Neoplasms, Signal Transduction. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
One of the most common prevalent forms of cancer in the world is oral squamous cell carcinoma (OSCC). In the present study, we explore the chemotherapeutic effect of Sclareol on human oral carcinoma KB cells in scientifically found that cellular and molecular alterations. The human oral carcinoma KB cell and African green monkey kidney normal cell line (Vero) were evaluated for a several types of investigations following they had been various concentrations of Sclareol (5–50 µM) and cisplatin (0–10 µM) for 24 h. Additionally, we exhibited that sclareol induces cytotoxicity effect by MTT assay, Reactive oxidative stress (ROS) was measured by DCFH‐DA staining assay, loss of mitochondrial membrane potential (Δψm) was assessed by Rho123 staining method, nuclear condensation, and apoptotic morphological changes was investigated by DAPI and AO/EtBr staining in KB cells. Sclareol promoted oxidative stress via an imbalance in redox status and increased DNA damage in human oral carcinoma KB cells. Besides, Sclareol induces apoptosis by activating dependent p21 waf1/cip1 , thereby down‐regulating the expression levels of phosphorylation of Rb (ser 780), cyclin D1, and cyclin‐E. Furthermore, it is associated with mitochondrial‐mediated apoptotic and proapoptotic markers, as evidenced by the downregulated Bcl‐2 protein and the upregulation of (Bax, Cytochrome C, Cleaved PARP, Cleaved Caspase and Caspase‐9 &‐3) induced apoptosis signaling through p53 independent pathways. Therefore, our present study findings suggest that Sclareol could be the productive new chemotherapeutic agent for against oral squamous cell carcinoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Biotechnology, Faculty of Science, Annamalai University, Annamalainagar, Tamil Nadu, India.
ORCID-Profile: Anandhi Nallu, Suresh Kathiresan, Theerthu Azhamuthu, Nihal Ahamed Abulkalam Asath, Pugazhendhi Ravichandran
Zitieren
APA
Nallu, A., Kathiresan, S., Azhamuthu, T., Ramadoss, H., Asath, N. A. A., Ravichandran, P., & Vasu, R. (2026). Sclareol Inhibit Cell Growth and Induces Apoptosis via Activation of p53/p21 Signaling Pathways in Human Oral Squamous Cell Carcinoma Cells. Journal of Biochemical and Molecular Toxicology, 40(9). https://doi.org/10.1002/jbt.71106
Vancouver
Nallu A, Kathiresan S, Azhamuthu T, Ramadoss H, Asath NAA, Ravichandran P, et al. Sclareol Inhibit Cell Growth and Induces Apoptosis via Activation of p53/p21 Signaling Pathways in Human Oral Squamous Cell Carcinoma Cells. Journal of Biochemical and Molecular Toxicology. 2026;40(9). doi:10.1002/jbt.71106
BibTeX
@article{Nallu2026,
author = {Nallu, Anandhi and Kathiresan, Suresh and Azhamuthu, Theerthu and Ramadoss, Hemavardhani and Asath, Nihal Ahamed Abulkalam and Ravichandran, Pugazhendhi and Vasu, Rajeswari},
title = {Sclareol Inhibit Cell Growth and Induces Apoptosis via Activation of p53/p21 Signaling Pathways in Human Oral Squamous Cell Carcinoma Cells},
journal = {Journal of Biochemical and Molecular Toxicology},
year = {2026},
volume = {40},
number = {9},
doi = {10.1002/jbt.71106}
}
EUVIMED